Two clinical developments in oncology drew attention this week, centered on pancreatic cancer and off-the-shelf CAR-T therapy for B-cell lymphoma. Allogene Therapeutics Chief Medical Officer Zach Roberts discussed new study results supporting the company's allogeneic CAR-T program, which is designed to treat B-cell lymphoma without requiring patient-specific cell manufacturing. CAR-T therapies traditionally rely on extracting and engineering a patient's own immune cells, a process that is costly and time-consuming. Allogene's off-the-shelf approach uses donor-derived cells manufactured in advance, which could meaningfully reduce both cost and treatment delay if the clinical data holds. The lymphoma data adds to a growing body of evidence that allogeneic CAR-T is viable, though regulatory and durability questions remain live issues for the field. A separate segment addresses a pancreatic cancer breakthrough, a disease with notoriously poor survival rates and few effective systemic options. Investors and clinicians tracking oncology pipelines should watch both programs for upcoming data readouts and any partnership or licensing activity they may catalyze.
Apple has raised MacBook and iPad prices in India by 20% to 42%, citing a sharp surge in memory chip costs driven by AI data centre demand. Micron, the leading memory supplier, reported 86% gross margins, confirming that supply pressures have fundamentally shifted component pricing across the consumer electronics
India's central government will take a 1-2% stake in AI unicorn Sarvam once its $300 million funding round closes, converting compute subsidies provided under the IndiaAI Mission into equity. The move sets a precedent for how the government accounts for public support given to homegrown AI startups.
Apple announced iOS 27 at WWDC 2026, featuring a redesigned Siri as a standalone app with chat history, apps launching up to 30 percent faster, and a refined Liquid Glass interface. A developer preview is live now, with public release expected around September 2026.
Apple's WWDC 2026 keynote unveiled a fully redesigned Siri and confirmed iOS 27 alongside updates for iPadOS, visionOS, watchOS, and macOS. The Siri overhaul is the most strategically significant move, targeting a competitive gap with Google and Microsoft in AI assistants.
